News
Cosmo Pharmaceuticals on Friday reported the renewal of its multi-year manufacturing and supply agreement with Takeda ...
Nelly Korda and rising English star Lottie Woad were among the top 10 on the leaderboard and still nine shots behind at the ...
August 8, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-driven healthcare and specialty pharmaceuticals, today announced the renewal of its multi-year manufacturing and supply ...
The growing healthcare burden posed by hepatocellular carcinoma, the most common subtype of liver cancer, has prompted the ...
6d
The Manila Times on MSNYamashita, Takeda pull away at Women’s British OpenMiyu Yamashita started and finished with short birdie putts and was flawless in between as she posted a 7-under 65 on Friday ...
Leo Barella, a former executive at Takeda, has joined Booz Allen Hamilton as senior vice president and chief information ...
Q2 2025 Earnings Call Transcript August 6, 2025 Mirum Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...
NDA for icotrokinra for the treatment of adults and adolescents 12 years of age and older with moderate to severe plaque ...
Novavax raised its full-year adjusted revenue forecast on Wednesday, banking on higher sales tied to its vaccine supply ...
Key Points GAAP loss per share of $0.55 in Q2 2025 beat analyst estimates by $1.13. GAAP revenue of $5.5 million in Q2 2025 missed expectations by 26%. Advanced key clinical programs, with first U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results